Fecal occult blood testing, a patient-administered test that is much less expensive than a colonoscopy, is a valid option for early detection of colon cancer, according to a report in the Canadian ...

After a maximum follow-up of 14 years, the mean screening participation rate was 63.3%. Those who underwent early screening had reduced risk for colorectal cancer mortality and excess mortality.

Credit: Reese Pharmaceutical. ColoTest is designed to detect blood in stool, which may be an early indication for colorectal cancer, diverticulitis, gastrointestinal disorders, colitis or polyps.

June 8, 2009 (Chicago, Illinois) – Detection of "long DNA" in the stool, when combined with fecal occult blood testing, detects colorectal cancers with a specificity of 90%. This approach is "among ...

About The Study: This study of routine screening with fecal occult blood testing found a 14% decrease in colorectal cancer mortality associated with screening. The true association of screening with ...

This indicates that the test is as effective as colonoscopy in reducing colorectal cancer mortality in screening [programs],” notes a summary of the study findings from Hospi ...

A groundbreaking blood test for colorectal cancer screening has received approval from the U.S. Food and Drug Administration (FDA), offering the potential to revolutionize early detection for one of ...

Please provide your email address to receive an email when new articles are posted on . Annual fecal immunochemical testing was the most effective and cheapest CRC screening method for underserved ...

Cologuard is a colon cancer screening test you can do at home. It’s a noninvasive, stool-based test that comes in a kit. You use the kit to collect a stool sample. Then you send the sample to a lab ...

The U.S. Preventive Services Task Force recommends colorectal cancer screening for all adults starting at age 45. After age 75, the task force recommends talking with your health care team to decide ...